-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In order
to strengthen drug quality supervision and ensure the safety of public drug use, china's multi-provincial and municipal drug regulatory departments have carried out drug supervision and sampling throughout the provinceRecently, another batch of Chinese medicine drink tablets were sampled out of the unqualifiedA batch of unqualified drink tablets were exposedYunnan Province: 12 varietiesRecently, Yunnan Provincial Drug Administration issued the first issue of 2020 non-conforming drug quality announcement, sampling found that there are 12 varieties of Gegen, Tianma, Zhebei mother, etcunqualified, areChinese medicineand Chinese medicine drink tabletsHunan Province: 37 varieties
Hunan Provincial Drug Administration recently organized the province's production, operation, use of drugs for spot checksThe sampling found that there were 38 batches of drugs that did not meet the regulations, involving 37 varieties of 32 production enterprisesXinjiang: 44 batches ofrecently, the Xinjiang Drug Administration issued 2 drug quality announcements, a total of 47 batches of non-conforming drugs were announced, involving 28 enterprisesAmong them, non-conforming drugs include 44 batches of Chinese medicine tablets, involving 26 pharmaceutical companiesIts non-conforming items include traits, identification, total ash, content determination and so onAnd there are 19 batches of Chinese medicine tablets note for non-enterprise productsShandong Province: 7 batches ofthe new drug quality sampling notice issued by the Shandong Provincial Drug Administration (2020 No2) shows that, after verification and confirmation, 10 varieties of 10 production enterprises (preparation units) marked a total of 10 batches of drugs, after sampling does not meet the standard requirementsAmong the unqualified drugs, there are 7 batches of Chinese medicine tablets, involving 5 varietiesHenan: 15 batches ofHenan Province Drug Administration also recently issued a notice of non-conforming drugsThe circular showed that 15 batches of medicinal herbs were not qualified, due to the above-standard pesticide residues and acid insoluble ash, total ash, free vantium, and non-compliance with the base valueThe supervision of the drinking film industry will become increasingly strict
Chinese medicine tablets can be said to be the "regular customers" in the list of drug sampling failuresIndustry analysis pointed out that at present, many Chinese herbal medicine cultivation technology is not mature, coupled with the origin of medicinal herbs, defects in the concocting process, improper storage and other factors, may lead to Chinese medicine tablet sin sin sin items do not meet the requirementsBecause the quality of Chinese medicine tablets is related to clinical efficacy and patient safety, so it is very necessary to strengthen the rectification of the drinking tablet industry, to carry out better regulation and supervisionthe release of the newly revised Drug Administration Law in 2019, the Chinese medicine drink tablet industry reshuffle intensified, a number of small and medium-sized enterprises that do not meet the requirements of the regulations gradually withdraw from the market Recently, the State Drug Administration also held a teleconference to summarize the 2019 Chinese medicine drink tablets centralized rectification work and the 2020 Chinese medicine drink tablets special rectification work to do the deployment and mobilization it is clear that the special rectification activities of Chinese medicine tablets is one of the four special rectification activities in the 2020 drug safety supervision work plan of the State Drug Administration, and in February this year, a special issue of the "Chinese medicine drink tablets special rectification work programme", the program put forward the overall goal and work points for the special rectification work meeting requires that drug regulatory departments at all levels should, as required, unify their thinking, take concerted action, implement the responsibility of territorial supervision, carefully inspect the production and operation and use units of Chinese medicine tablets and preparations, resolutely investigate and punish illegal and illegal acts;